R&D 

Copyright(c)2017 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 243 Gong Ye Bei Road, Jinan, Shandong 250100, CHINA

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

ABOUT US

Qilu Antibiotics passed US FDA inspection with no 483 observation

Classification:
Company news
Author:
QILU PHARMACEUTICAL
Source:
QILU PHARMACEUTICAL
Release time:
2018/08/16 16:58
Page view
[Abstract]:
QiluPharmaceuticalannouncesthatitssubsidiaryQiluAntibioticssuccessfullypassedtheUSFDAinspectionwithno483observations.TheinspectioncommencedonAugust8,2018andwascompletedonAugust16,2018.QiluAntibioticsi

Qilu Pharmaceutical announces that its subsidiary Qilu Antibiotics successfully passed the US FDA inspection with no 483 observation. The inspection commenced on August 8, 2018 and was completed on August 16, 2018.

Qilu Antibiotics is the world’s major supplier of Cephalosporin products with the capacity of 2000 tons/year. Products have been exported to more than 40 countries, including US, EU, Japan, Korea, etc.

NEWS